Cars.com
CARS
New Fortress Energy
NFE
Hutchmed (China)
HCM
4
Collegium Pharmaceutical
COLL
5
Dorian LPG
LPG
US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 21.0000
- -1.3900-6.21%
Close Mar 11 16:00 ET
- 21.0000
- 0.00000.00%
Post 16:20 ET
230.02MMarket Cap-0.79P/E (TTM)
21.9600High20.1500Low126.94KVolume21.9600Open22.3900Pre Close2.65MTurnover2.78%Turnover RatioLossP/E (Static)10.95MShares28.420052wk High1.41P/B96.03MFloat Cap10.000052wk Low--Dividend TTM4.57MShs Float382.6000Historical High--Div YieldTTM8.08%Amplitude8.0000Historical Low20.8660Avg Price1Lot Size
Cidara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -94.52%1.28M | 0 | 0 | -94.07%302K | -67.58%8.46M | -63.87%23.28M | -73.45%2.76M | -77.38%9.22M | -18.11%5.09M | 267.24%26.11M |
| Operating revenue | -94.52%1.28M | --0 | --0 | -94.07%302K | -67.58%8.46M | -63.87%23.28M | -73.45%2.76M | -77.38%9.22M | -18.11%5.09M | 267.24%26.11M |
| Cost of revenue | 1.56M | 0 | ||||||||
| Gross profit | -73.57%6.9M | 26.11M | ||||||||
| Operating expense | 252.34%177.38M | 372.92%54.18M | 27.10%17.39M | -3.67%11.4M | -24.59%17.59M | -48.60%50.34M | -58.23%11.46M | -47.00%13.69M | -38.76%11.84M | -8.06%23.33M |
| Selling and administrative expenses | 51.80%20.62M | 112.01%7.31M | 50.50%4.97M | 49.20%4.75M | 34.57%6M | -33.90%13.58M | -37.19%3.45M | -42.92%3.3M | -21.92%3.18M | -14.35%4.46M |
| -General and administrative expense | 51.80%20.62M | ---- | ---- | 49.20%4.75M | 34.57%6M | -33.90%13.58M | ---- | ---- | -21.92%3.18M | -14.35%4.46M |
| Research and development costs | 326.41%156.76M | 485.19%46.87M | 19.67%12.43M | -23.10%6.66M | -38.56%11.59M | -52.51%36.76M | -63.50%8.01M | -48.18%10.39M | -43.25%8.66M | -6.43%18.87M |
| Operating profit | -550.78%-176.1M | -522.71%-54.18M | -289.30%-17.39M | -64.51%-11.1M | -484.43%-10.69M | 19.23%-27.06M | 48.97%-8.7M | -129.94%-4.47M | 48.54%-6.75M | 115.23%2.78M |
| Net non-operating interest income expense | 191.28%5.81M | 244.02%1.81M | 203.26%1.86M | 184.75%1.77M | 57.33%365K | 944.50%2M | 225.31%527K | 1,014.55%613K | 10,483.33%623K | 1,260.00%232K |
| Non-operating interest income | 191.28%5.81M | 244.02%1.81M | 203.26%1.86M | ---- | 57.33%365K | 944.50%2M | 225.31%527K | 1,014.55%613K | ---- | --232K |
| Total other finance cost | ---- | ---- | ---- | -184.75%-1.77M | ---- | ---- | ---- | ---- | -10,483.33%-623K | ---- |
| Other net income (expense) | -84.88M | |||||||||
| Special income (charges) | ---- | ---- | ---- | ---84.88M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --84.88M | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -579.40%-170.29M | -540.68%-52.37M | -302.98%-15.54M | -1,438.12%-94.21M | -442.71%-10.33M | 24.76%-25.07M | 51.60%-8.17M | -125.74%-3.86M | 53.31%-6.13M | 116.48%3.01M |
| Income tax | 0 | 0 | 0 | 0 | -94.49%15K | -97.43%7K | -32K | 40K | ||
| Net income | -640.60%-169.83M | -1,527.98%-52.31M | -75.52%-15.99M | -569.47%-91.21M | -442.71%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -160.80%-9.11M | -3.85%-13.62M | 116.48%3.01M |
| Net income continuous Operations | -578.99%-170.29M | -540.13%-52.37M | -306.36%-15.54M | -1,428.14%-94.21M | -442.71%-10.33M | 25.32%-25.08M | 52.33%-8.18M | -125.52%-3.82M | 53.01%-6.17M | 116.48%3.01M |
| Net income discontinuous operations | -78.41%464K | -98.75%62K | 91.48%-450K | 140.23%3M | ---- | --2.15M | --4.97M | ---5.28M | ---7.46M | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -640.60%-169.83M | -1,527.98%-52.31M | -75.52%-15.99M | -569.47%-91.21M | -442.71%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -160.80%-9.11M | -3.85%-13.62M | 116.48%3.01M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 636K | ||||||||
| Net income attributable to common stockholders | -640.60%-169.83M | -1,527.98%-52.31M | -75.52%-15.99M | -569.47%-91.21M | -534.41%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -176.55%-9.11M | -3.85%-13.62M | 113.00%2.38M |
| Basic earnings per share | -409.52%-26.75 | -678.26%-5.37 | -21.29%-2.45 | -561.92%-19.99 | -480.00%-2.28 | 45.31%-5.25 | 81.84%-0.69 | -159.41%-2.02 | 20.53%-3.02 | 111.11%0.6 |
| Diluted earnings per share | -409.52%-26.75 | -678.26%-5.37 | -21.29%-2.45 | -561.92%-19.99 | -480.00%-2.28 | 45.31%-5.25 | 81.84%-0.69 | -159.41%-2.02 | 20.53%-3.02 | 111.11%0.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025